ENDPOINTS

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

German pharma company Merck KGaA confirmed that it is in talks to acquire SpringWorks Therapeutics, though a deal has yet to be announced. Merck confirmed the discussions hours after Reuters ...

Feb 10, 2025 - 21:51
 0
Merck KGaA confirms interest in acquiring cancer biotech SpringWorks
German pharma company Merck KGaA confirmed that it is in talks to acquire SpringWorks Therapeutics, though a deal has yet to be announced. Merck confirmed the discussions hours after Reuters ...
Read More

Tags:

Previous Article

Google’s DeepMind AI Can Solve Math Problems on Par with Top Human Solvers

Next Article

Firefly's Blue Ghost lunar lander leaves Earth orbit to head for the moon

Related Posts

Roivant discontinues lung disease drug; Bio-Thera, Intas make biosimilar deal

Roivant discontinues lung disease drug; Bio-Thera, Inta...

Feb 10, 2025  0

Hims’ Super Bowl ad has drawn criticism from lawmakers — and now Novo Nordisk

Hims’ Super Bowl ad has drawn criticism from lawmakers ...

Feb 10, 2025  0

Novo Nordisk takes aim at Roche in hemophilia A, but is way behind

Novo Nordisk takes aim at Roche in hemophilia A, but is...

Feb 9, 2025  0